We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (FARM)

This study has been terminated.
(Company decision to modify the ferroquine development strategy; discontinuation not due to safety or activity unexpected findings)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00988507
First Posted: October 2, 2009
Last Update Posted: June 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sanofi